Строительство

Новострой


Скачать с ютуб Bristol Myers Squibb CEO expects Zeposia to renew company's medicine portfolio

00:01:35 1,2 тыс. просмотров

Скачать видео: Скачать MP3: Если кнопки скачивания не загрузились НАЖМИТЕ ЗДЕСЬ или обновите страницу

\"Zeposia is one of the key medicines that we count on for the renewal of our portfolio, and things are progressing very well,\" Bristol-Myers Squibb CEO Giovanni Caforio said of the phase three trial of a bowel disease treatment. Subscribe to CNBC PRO for access to investor and analyst insights: https://cnb.cx/2Vtntx6

» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast

Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC

https://www.cnbc.com/select/best-credit-cards/

#CNBC
#CNBCTV

Comments